2881 - 2890 of 5832 Results
Title
Year
-
OPENTitle: The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2134End Page: 2136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28354Best OA location URL: https://eprints.ncl.ac.uk/file_store/production/271876/552911A9-469D-41EA-AA8A-F7B7D5C04187.pdfCitation Count: 4
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 16
-
OPENTitle: Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regionsJournal Name: Clinical EpigeneticsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13148-020-00944-zBest OA location URL: https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-020-00944-zCitation Count: 62
-
OPENTitle: Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/1694547Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/1694547.pdfCitation Count: 12
-
OPENTitle: Altered Functional Network Associated With Cognitive Performance in Early Parkinson Disease Measured by Eigenvector Centrality MappingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.554660Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.554660/pdfCitation Count: 7
-
OPENTitle: Classification of PPMI MRI scans with voxel-based morphometry and machine learning to assist in the diagnosis of Parkinson’s diseaseJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 198Issue #:Start Page: 105793End Page: 105793Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105793Best OA location URL: https://doi.org/10.1016/j.cmpb.2020.105793Citation Count: 87
- Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology2020OPENTitle: Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and PathologyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.577435Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.577435/pdfCitation Count: 60
-
OPENTitle: Robust Bayesian Analysis of Early-Stage Parkinson’s Disease Progression Using DaTscan ImagesJournal Name: IEEE Transactions on Medical ImagingPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 40Issue #: 2Start Page: 549End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/tmi.2020.3031478Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899013Citation Count: 8
-
OPENTitle: Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-74195-6Best OA location URL: https://www.nature.com/articles/s41598-020-74195-6.pdfCitation Count: 32
-
OPENTitle: A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerabilityJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 69End Page: 74Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770052Citation Count: 26